These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3914360)

  • 1. [Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
    Ciavarella N; Antoncecchi S; D'Elia N
    Cardiologia; 1985 Apr; 30(4):301-7. PubMed ID: 3914360
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of Persantine in preventing thromboembolism following valve replacement.
    Arrants JE; Hairston P
    Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
    Sullivan JM; Harken DE; Gorlin R
    N Engl J Med; 1971 Jun; 284(25):1391-4. PubMed ID: 4931099
    [No Abstract]   [Full Text] [Related]  

  • 8. Dipyridamole combined with anticoagulant in prevention of early postoperative thromboembolism after cardiac valve replacement.
    Kawazoe K; Fujita T; Manabe H
    Thromb Res Suppl; 1990; 12():27-33. PubMed ID: 2082485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced modification of thrombocyte turnover in patients with artificial heart valves].
    Kummer H; Hunziker HR; Althaus U
    Schweiz Med Wochenschr; 1974 Jan; 104(4):142-4. PubMed ID: 4811472
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
    Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism.
    Chesebro JH; Steele PM; Fuster V
    Postgrad Med; 1985 Jul; 78(1):48-50, 57-71. PubMed ID: 3160013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
    Chesebro JH; Fuster V; Elveback LR; McGoon DC; Pluth JR; Puga FJ; Wallace RB; Danielson GK; Orszulak TA; Piehler JM; Schaff HV
    Am J Cardiol; 1983 May; 51(9):1537-41. PubMed ID: 6342354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
    Mok CK; Boey J; Wang R; Chan TK; Cheung KL; Lee PK; Chow J; Ng RP; Tse TF
    Circulation; 1985 Nov; 72(5):1059-63. PubMed ID: 3899404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.
    Harker LA; Slichter SJ
    N Engl J Med; 1970 Dec; 283(24):1302-5. PubMed ID: 5478451
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of platelet activity in patients with prosthetic heart valves.
    Bran M; Capel P; Messin R
    Rev Med Brux; 1980 Feb; 1(2):71-5. PubMed ID: 7403713
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet survival time following aortic valve replacement.
    Steele P; Weily H; Davies H; Ppppas G; Genton E
    Circulation; 1975 Feb; 51(2):358-62. PubMed ID: 1112016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA; Hirsh J; Gent M; Genton E
    Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Arterial thromboembolism and prosthetic heart valves. Effects of acetylsalicylic acid.
    Dale J; Myhre E; Storstein O; Stormorken H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):587-8. PubMed ID: 1105879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.